mRNA Vaccines: Confidential Pfizer Document Shows It Observed 1.6 Million Adverse Events
June 29, 2023
Micronutrient Deficiencies: The Socio-Economic Case For Supplementation In Mothers
June 29, 2023

Low-Dose Aspirin Use Associated With 20 Percent Increased Anemia Risk In Older Adults


An analysis has found that the use of low-dose aspirin is associated with a 20 percent increased incidence of anemia and decline in ferritin, or blood iron levels, in otherwise healthy older adults.


Aspirin is far from being the ‘wonder drug’ or ‘miracle drug’ it is often portrayed as in the mainstream media.

Researchers have found that elderly people who take daily aspirin tablets after a heart attack or stroke are at much greater risk of potentially fatal internal bleeding than originally thought. Published in The Lancet medical journal in 2017 by scientists at Oxford University, the analysis suggests that more than 3,000 patients die every year in the UK from long-term use of aspirin. Significantly, for people over the age of 75, the risk of suffering a disabling or deadly bleed from treatment with the drug was shown to be ten times higher than for younger patients.

In healthy, elderly people, a large clinical trial published in 2019 found that daily low-dose aspirin tablets have no effect on prolonging life. Other research has revealed that men who take daily aspirin tablets have nearly double the risk of melanoma, a type of skin cancer. The drug has also been shown to accelerate the progression of advanced cancers in older adults.

To learn more about the dangers of aspirin, including how it depletes body levels of vitamin C, see this article on our website.